US2003143279A1PendingUtilityA1
Method for preparing microparticles having a selected polymer molecular weight
Est. expiryMay 19, 2020(expired)· nominal 20-yr term from priority
B01J 13/02A61K 9/1694A61K 31/519A61K 9/1647
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for preparing microparticles having a selected polymer molecular weight. The hold time and temperature of a solution containing a nucleophilic compound and a polymer having a starting molecular weight are controlled in order to control the molecular weight of the polymer in the finished microparticle product. In this manner, a selected polymer molecular weight in the finished microparticle product can be achieved from a variety of starting material molecular weights.
Claims
exact text as granted — not AI-modifiedWhat Is claimed is:
1 . A method of preparing microparticles having a selected microparticle polymer molecular weight, comprising:
(a) combining a first phase comprising a nucleophilic compound, a polymer having a starting molecular weight, and a solvent for the polymer, with a second phase to form an emulsion; (b) extracting solvent from the emulsion, thereby forming microparticles; and (c) maintaining the first phase at a hold temperature for a hold period prior to step (a), the hold period of sufficient duration to allow the starting molecular weight of the polymer to reduce so that the selected microparticle polymer molecular weight is achieved.
2 . The method of claim 1 , further comprising:
(d) increasing the hold temperature, thereby increasing molecular weight decay of the polymer to reduce a duration of the hold period.
3 . The method of claim 1 , further comprising:
(d) decreasing the hold temperature, thereby decreasing molecular weight decay of the polymer to increase a duration of the hold period.
4 . The method of claim 1 , wherein the starting molecular weight is in the range of from about 50 kD to about 250 kD.
5 . The method of claim 1 , wherein the hold period is in the range of from about 0.05 hour to about 6 hours.
6 . The method of claim 1 , wherein the hold temperature is in the range of from about 15° C. to about 35° C.
7 . The method of claim 1 , wherein step (b) comprises combining the emulsion and an extraction medium.
8 . The method of claim 1 , wherein the nucleophilic compound is selected from the group consisting of risperidone, 9 -hydroxyrisperidone, and pharmaceutically acceptable salts thereof.
9 . The method of claim 8 , wherein the solvent comprises benzyl alcohol and ethyl acetate.
10 . The method of claim 1 , wherein the polymer is selected from the group consisting of poly(glycolic acid), poly-d,l-lactic acid, poly-l-lactic acid, and copolymers of the foregoing.
11 . The method of claim 10 , wherein the polymer is poly(d,l-lactide-co-glycolide) having a molar ratio of lactide to glycolide in the range of from about 100:0 to about 50:50.
12 . The method of claim 1 , further comprising:
(d) mixing the first phase during the hold period.
13 . The method of claim 1 , wherein the selected microparticle polymer molecular weight is in the range of from about 10 kD to about 185.0 kD.
14 . The method of claim 4 , wherein the selected microparticle polymer molecular weight is in the range of from about 10 kD to about 185.0 kD.
15 . The method of claim 1 , wherein the starting molecular weight reduces by an amount in the range of from about 10% to about 50% to reach the selected microparticle polymer molecular weight.
16 . The method of claim 4 , wherein the starting molecular weight reduces by an amount in the range of from about 10% to about 50% to reach the selected microparticle polymer molecular weight.
17 . The method of claim 13 , wherein the starting molecular weight reduces by an amount in the range of from about 10% to about 50% to reach the selected microparticle polymer molecular weight.
18 . The method of claim 1 , further comprising:
(d) adding an inactive agent to the first phase.
19 . The method of claim 1 , wherein the nucleophilic compound is an active agent.
20 . The method of claim 1 , wherein the nucleophilic compound is an inactive agent.
21 . The method of claim 1 , wherein the nucleophilic compound is basic.
22 . The method of claim 1 , wherein the nucleophilic compound is naltrexone.
23 . The method of claim 1 , wherein the nucleophilic compound is oxybutynin.
24 . Microparticles having a selected microparticle polymer molecular weight prepared by the method of claim 1 .
25 . Microparticles having a selected microparticle polymer molecular weight prepared by the method of claim 8 .
26 . Microparticles having a selected microparticle polymer molecular weight prepared by the method of claim 10 .
27 . Microparticles having a selected microparticle polymer molecular weight prepared by the method of claim 22.Join the waitlist — get patent alerts
Track US2003143279A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.